trending Market Intelligence /marketintelligence/en/news-insights/trending/lsMwwnDwtWFYDk1SVh0k3g2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Biogen board authorizes $5B share buyback program

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Biogen board authorizes $5B share buyback program

Biogen Inc. said its board of directors authorized a program to buy back up to $5 billion of its common stock.

The share repurchase program does not have an expiration date. All share repurchases under the program will be retired.

The current program is in addition to the buyback program authorized by the Cambridge, Mass.-based drugmaker's board in March.

Biogen develops and manufactures therapies for neurological and neurodegenerative diseases.